Diabulimia

What it is

Diabulimia is a life-threatening eating disorder specific to people with type 1 diabetes, in which insulin doses are deliberately restricted or omitted to induce weight loss — affecting an estimated 30 to 40% of young women with type 1 diabetes at some point in their lives. Also called ED-DMT1 (eating disorder-diabetes mellitus type 1), diabulimia is not yet a formal DSM-5 diagnosis, but it is increasingly recognized by diabetes specialists and eating disorder clinicians as a distinct and serious condition requiring integrated treatment. In Canada, where approximately 300,000 people live with type 1 diabetes (Diabetes Canada), the condition remains underdiagnosed partly because its signs are often attributed to poor diabetes self-management rather than a co-occurring psychiatric disorder.

The core mechanism is straightforward: without adequate insulin, glucose cannot enter cells and is instead excreted in the urine, producing rapid weight loss. That same insulin deficiency forces the body to break down fat and muscle for fuel — the same metabolic state that drives diabetic ketoacidosis (DKA). People with diabulimia develop serious complications on average 15 years earlier than those with well-managed type 1 diabetes, and mortality rates are significantly higher.

Causes and mechanism

Diabulimia sits at the intersection of type 1 diabetes physiology and the psychological drivers common to eating disorders. Several factors converge:

• Insulin-related weight gain: Starting or optimizing insulin therapy frequently causes weight gain, which can be distressing for adolescents and young adults already sensitive to body image.
• Food preoccupation: T1D management demands constant carbohydrate counting, meal timing, and glucose monitoring — a framework that can foster an unhealthy relationship with food.
• Shared eating disorder risk factors: Perfectionism, low self-esteem, body image dissatisfaction, and a need for control are risk factors for eating disorders generally and appear at elevated rates in people with T1D.
• Reinforcement of restriction: The initial experience of weight loss from omitting insulin can become self-reinforcing before the metabolic consequences become apparent.
• Diabetes burnout: The relentless cognitive load of managing a chronic condition can lead to intentional non-adherence as psychological relief.
• Sociocultural pressure: Cultural emphasis on thinness is particularly intense during adolescence and young adulthood, the peak period of T1D onset in females.

Symptoms and diagnosis

Diabulimia is difficult to identify because the psychological component is often concealed and physical signs can be mistaken for poor diabetes management.

Metabolic and physical warning signs:

• Persistently elevated HbA1c despite reported adherence
• Recurrent DKA episodes without a clear medical trigger
• Unexplained weight loss
• Polyuria and polydipsia (frequent urination and excessive thirst)
• Fatigue and difficulty concentrating

Behavioural and psychological warning signs:

• Secrecy or evasiveness about insulin use and glucose readings
• Anxiety or distress specifically linking food, weight, and diabetes management
• Avoidance of diabetes clinic appointments
• Skipping mealtime insulin doses in particular
• Intense fear of weight gain or distorted body image

Long-term complications that may accelerate:

Complication	Mechanism
Diabetic retinopathy	Chronic hyperglycaemia damages retinal vessels; blindness risk rises
Diabetic nephropathy	Sustained high glucose accelerates kidney filtration damage
Peripheral neuropathy	Nerve damage from prolonged glucose toxicity
Cardiovascular disease	Atherosclerosis accelerated by metabolic dysregulation
Bone density loss	Insulin deficiency impairs osteoblast function

Diagnosis involves reviewing HbA1c trends and glucose patterns, applying validated eating disorder screening tools by clinicians experienced in both fields, assessing insulin use history, and screening for existing complications.

Treatment options

Effective treatment requires a multidisciplinary team addressing both the diabetes and the eating disorder simultaneously — treating one without the other rarely works.

• Specialist team: Ideally includes a diabetes specialist (endocrinologist or internist), a psychologist or psychiatrist with eating disorder experience, a registered dietitian familiar with T1D, and a diabetes nurse educator.
• Cognitive behavioural therapy (CBT): The most evidence-supported psychological intervention for eating disorders; adapted versions for the diabetes context address insulin-specific fears and food-related cognitions.
• Diabetes education reframing: Directly addressing misconceptions about insulin and weight, and building a sustainable, non-restrictive approach to eating within T1D management.
• Medical stabilization: Treating DKA, electrolyte disturbances, and complications. Any rapid improvement in glycaemic control must be managed carefully — too-fast normalization of blood sugar can worsen certain complications in the short term.
• Peer support: Connection with others who have lived experience of ED-DMT1 can reduce isolation and shame, which are significant barriers to treatment engagement.

In Canada, integrated programs combining diabetes and eating disorder care exist at some academic health centres, but access is uneven across provinces. Patients in regions without specialist services may need to coordinate between a diabetes clinic and a separate eating disorder program. Telehealth platforms such as Maple or Cleo can help bridge gaps for initial assessment and ongoing psychological support, though they are not substitutes for specialist in-person care.

When to see a clinician in Canada

Seek help promptly if you have type 1 diabetes and:

• Find yourself deliberately skipping or reducing insulin doses to prevent weight gain
• Are preoccupied with weight or body shape in ways that affect your diabetes management
• Have a persistently elevated HbA1c but feel unable or unwilling to change the pattern
• Are experiencing recurrent DKA without a clear medical explanation
• Feel significant shame, secrecy, or distress around insulin use or food

Disclosing this behaviour to a healthcare provider can feel difficult, but it is the necessary first step. In Canada, starting points include your diabetes care team, a family physician, or contacting the National Eating Disorder Information Centre (NEDIC) helpline at 1-866-NEDIC-20. Diabetes Canada also maintains a directory of diabetes health-care providers who can coordinate referrals.

Limitations and open questions

Research is still emerging on several fronts. Diabulimia has no formal DSM-5 classification, which limits insurance coverage for specialized treatment in some Canadian provinces and makes epidemiological tracking inconsistent. Prevalence estimates (30–40% of young women with T1D engaging in some degree of insulin restriction) vary widely across studies depending on how restriction is defined and measured. Evidence for specific psychotherapeutic protocols adapted to ED-DMT1 — as distinct from eating disorders generally — remains limited; most treatment recommendations are extrapolated from broader eating disorder literature. The condition is also understudied in males, older adults, and people with type 2 diabetes on insulin. Health Canada has not issued specific clinical guidance on diabulimia, and provincial eating disorder programs vary considerably in their capacity to manage patients with concurrent T1D. Long-term outcomes data from integrated treatment programs are sparse.